About Credent Connect N Care IPO
Credent Connect N Care IPO Details
Credent Connect N Care IPO is a 100% book-built issue of ₹93.89 crore, entirely a fresh issue of 49.68 lakh shares, with a face value of ₹10 per share. The company filed a DRHP with SEBI on March 31, 2026.
The price band of the issue is set at between ₹179 to ₹189 per share and the lot size for an application is 600 shares. The minimum amount of investment required by an individual investor is ₹2,26,800 (1,200 shares). The IPO will open for subscription from August 13 to 17, 2026, on the NSE SME platform, with a tentative listing date fixed as August 20, 2026. The book-running lead manager of the issue is Hem Securities Limited, while the registrar to the issue is KFin Technologies Limited.
Credent Connect N Care IPO Date & Timeline
The Credent Connect N Care IPO is officially set to open for subscription on Aug 13, 2026 and will close on Aug 17, 2026. The company initially filed its Draft Red Herring Prospectus (DRHP) on March 31, 2026 and has now finalized its schedule following SEBI approval. Once the subscription window closes, allotment is expected on Aug 18, 2026. Following this, the firm will initiate refunds and credit shares to successful investors' demat accounts on Aug 19, 2026. Finally, shares of Credent Connect N Care Ltd. are tentatively scheduled to list on the stock exchanges on Aug 20, 2026.
Credent Connect N Care IPO Timeline
| IPO Open Date | Thu, Aug 13, 2026 |
| IPO Close Date | Mon, Aug 17, 2026 |
| Basis of Allotment | Tue, Aug 18, 2026 |
| Initiation of Refunds | Wed, Aug 19, 2026 |
| Credit of Shares to Demat | Wed, Aug 19, 2026 |
| Listing Date | Thu, Aug 20, 2026 |
| Cut-off time for UPI mandate confirmation | - |
Credent Connect N Care IPO Details
| Detail | Description |
|---|---|
| IPO Date | 13 to 17 Aug, 2026 |
| Listing Date | 20 Aug, 2026 |
| Face Value | ₹ 10 Per Equity Share |
| Issue Price Band | ₹ 179 to ₹ 189 |
| Lot Size | 600 Shares |
| IPO Type | Fresh capital only |
| Total Issue Size | 49,68,000 shares (agg. up to ₹ 94 Cr) |
| Reserved for Market Maker | 2,52,000 shares (agg. up to ₹ 5 Cr) |
| Fresh Issue(Ex Market Maker) | 47,16,000 shares (agg. up to ₹ 89 Cr) |
| Net Offered to Public | 47,16,000 shares (agg. up to ₹ 89 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing At | NSE SME |
| Share Holding Pre Issue | 1,32,54,900 shares |
| Share Holding Post Issue | 1,82,22,900 shares |
Credent Connect N Care IPO GMP (Grey Market Premium)
“Grey Market Premium” or GMP is defined as the rate at which the IPO's shares are traded in the market before they are officially listed on the stock exchange.
The Credent Connect N Care IPO GMP is currently trading at ₹0, reflecting the sentiment of unofficial investors before the official listing. This premium suggests a potential listing price of ₹189, which is 0.00% above the issue price. While the Grey Market Premium is a key indicator of demand and investor appetite, it is important to remember that GMP is highly volatile and should not be the sole factor in your investment decisions.
IPO Estimated Listing Return
Based on the IPO Price of ₹189 (highest price band), the latest uploaded Grey Market Premium (GMP) of ₹0 and a lot size of 600 shares.
Credent Connect N Care GMP TREND (DAILY UPDATES)
| GMP Date | IPO Price | GMP | Last Updated |
|---|---|---|---|
| 10 Aug, 2026 | ₹189 | ₹0 | 10 Aug, 202610:44 AM |
Company Background
Credent Connect N Care Ltd. was incorporated on June 25, 2015, as a private limited company, named “Credent Cold Chain Logistics Private Limited”, focusing on temperature-controlled freight. Then, on January 12, 2024, the company changed its name from Credent Cold Chain to “Credent Connect N Care Private Limited”.
As the healthcare sector evolved, the company delivered integrated logistics, workforce solutions and technology-enabled support to healthcare institutions across India. Starting operations in 2015 with a small team of professionals and expanding from then into multiple healthcare services verticals. The company has its registered office in Ashok Vihar, Delhi and operates 2 warehouses and 4 branch offices across India, including in Mumbai, Pune, Chennai and Varanasi.
The shareholders passed the special resolution on September 15, 2025, but the fresh certificate of incorporation consequent to conversion was issued on October 28, 2025.
Operations & Product Range
Credent Connect N Care Ltd. mainly operates with a focus on delivering precise logistics for medical laboratories and hospitals, specialising in the transport of temperature-sensitive biological samples. These samples require careful handling within specific thermal ranges to ensure their integrity before laboratory analysis.
In addition to transportation logistics, the company offers home sample collection by trained phlebotomists and on-site workforce management, deploying technicians within partner institutions. It is a healthcare services provider delivering integrated logistics, workforce solutions and technology-enabled support to diagnostic laboratories.
Facilities & Capacity
Credent Connect N Care Ltd.’s network includes 4 branch offices and transit nodes in major areas like Delhi, Mumbai, Pune, Chennai and Varanasi, supported by strategically located warehouses for specialised materials. The company also operates 2 warehouses and its headquarters in Ashok Vihar, Delhi. Instead of owning all real estate, the company blends owned properties with flexible long-term leases for its headquarters and operational facilities. This approach, combined with software tracking systems and field equipment, enables rapid turnaround times.
Brands & Market Presence
Credent Connect N Care Ltd. is operating mainly within specialised commercial business circles under its corporate identifier and the recognised C3 Logistics banner and was successful in establishing a stable market position in the medical diagnostics support sector. The corporation has expanded its network within domestic trade routes, securing volume from national diagnostic labs and regional medical facilities. Its brand is founded on strict compliance with national logistics and specialized medical transport standards. By developing strong business relationships, it positions itself as a dependable partner to top healthcare diagnostic institutions, avoiding reliance on extensive D2C marketing.
Revenue Streams & Business Model
Credent Connect N Care Ltd. operates a specialised B2B healthcare model delivering end-to-end supply chain and manpower solutions to diagnostic labs, hospitals and pharmaceutical firms. Its business model relies on a multi-pronged service network, including temperature-controlled cold-chain transportation, intra-state and inter-state sample logistics and dedicated phlebotomy staffing. Primary revenue streams are generated through sample transportation fees, stationed lab workforce deployments, home sample collection services, corporate wellness camps and tech-driven logistics aggregation via its proprietary platform, C3 Post.
Financial Performance
Financially, in FY25, Credent Connect N Care Ltd. achieved a total income of ₹78.23 crore, from ₹76.02 crore in FY24. Operating performance improved as EBITDA rose from ₹4.30 crore to ₹4.99 crore. However, profit after tax (PAT) declined slightly from ₹2.66 crore in FY24 to ₹2.25 crore in FY25. The company expanded its balance sheet, increasing total assets from ₹26.41 crore to ₹29.50 crore, while net worth grew from ₹13.66 crore to ₹15.90 crore, with reserves and surplus reaching ₹15.70 crore.
Management & Shareholding
The promoters of Credent Connect N Care Ltd. are Ashok Kumar Sharma, Karan Sharma, Tarun Sharma, Dimple Sharma and Tanveen. Before the IPO, the promoters held an 87.52% stake in the company, but after the IPO, the shareholding of the promoters will be diluted to a 63.67% stake.
Board & Key Management
The leadership of Credent Connect N Care Ltd. is led by a team of experts with many years of experience. Tarun Sharma serves as the Chairman & Managing Director and gives strategic direction to the firm, as well as manages the daily operations, along with Whole-Time Director Karan Sharma. To ensure good governance, the board includes Independent Directors Vanita Yadav and Tejpal Singh for honest oversight. Together, this team uses its knowledge to help the company grow and stay successful.
Credent Connect N Care IPO Financial Information
Latest Revenue
77.94
₹ Crore
Profit After Tax
2.25
₹ Crore
Net Worth
15.90
₹ Crore
| Period Ended | Assets | Revenue From Operations | Profit After Tax | Net Worth | Reserves & Surplus | Total Borrowing | |||
|---|---|---|---|---|---|---|---|---|---|
| 31 Mar 2025 | 29.50 | 77.94 | 2.25 | 15.90 | 15.70 | — | |||
| 31 Mar 2024 | 26.41 | 75.73 | 2.66 | 13.66 | 13.46 | — | |||
| 31 Mar 2023 | 19.49 | 59.75 | 2.70 | 10.99 | 10.79 | — | |||
| Amount in ₹ Crore | |||||||||
Credent Connect N Care Key Performance Indicator
| KPI | Values(31 Mar 2025) |
|---|---|
| ROE | 15.20 % |
| ROCE | 16.96 % |
| Debt/Equity | - |
| RoNW | 14.13 % |
| PAT Margin | 2.88 % |
| EBITDA Margin | 6.41 % |
| Price to Book Value | 12.12 |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (Rs) | 1.69 | 1.23 |
| P/E (x) | 111.83 | 153.66 |
Credent Connect N Care IPO Objectives
The company intended to utilise the Credent Connect N Care IPO proceeds for the strategic purposes:
- • Investment in its wholly owned subsidiary, Credent Healthcare Private Limited, to meet its working capital requirements and to expand corporate wellness segment.
- • Funding working capital requirements
- • Repayment of debt (in part or in full)
- • General corporate purposes.
Credent Connect N Care IPO Review
Credent Connect N Care Ltd.'s position reveals an interest in an expanding segment of the medical support economy. By focusing on diagnostic sample logistics and specialised health staffing, the company is attempting to carve out a distinct position inside a highly technical space. The high barriers to entry, driven by the specialised requirements of medical temperature management, help shield organised market operators from generic transport competition.
Financially, the company has shown growth in its statements for FY25, as the total income was reported at ₹78.23 crore, profit after tax (PAT) was at ₹2.25 crore and EBITDA was at ₹4.99 crore. Notably, the PAT of the company was noted to decline from FY24 (₹2.66 crore) to FY25 (₹2.25 crore).
However, investors must balance these growth figures against visible operational variables, as the company operates under a highly concentrated client framework, deriving over 84% of its active operational revenues from its top 10 clients without long-term commitment guarantees. Moreover, the operational business remains dependent on managing a highly volatile field workforce and navigating complex corporate and labour compliance frameworks across multiple Indian states.
Overall, the IPO offers a corporate transition point from a family-led regional enterprise into an institutional logistics platform. The decision to use the capital proceeds to concurrently clear high-interest bank debt and invest in high-margin healthcare subsidiary equipment provides a logical path toward cleaner balance sheet operations. Investors will need to closely assess the final valuation multiples relative to the broader logistics sector once the pricing metrics are confirmed.
Conclusion
Credent Connect N Care IPO presents an opportunity to invest in an asset-light, specialised medical supply chain infrastructure business. Driven by structural shifts toward centralised laboratory processing in India, the long-term industry outlook remains positive. The group has leveraged its operational history in cold-chain logistics to build a nationwide framework capable of addressing the needs of medical diagnostics, clinical laboratories and corporate health campaigns. With this listing, the company aims to invest in its subsidiary’s expansion and operational requirements and to fund its own operational requirements and debt reduction.
Frequently Asked Questions
Recommended Advisory Services
Ready to take your company public? Explore our specialized IPO advisory services tailored for Indian enterprises.
The India IPO Publication is managed by an editorial team that includes highly experienced finance journalists, market researchers and professionals from the capital markets industry who strive to create high-quality content based on credible sources. Our editors write about IPOs, capital markets, corporate news, capital-raising strategies, regulations and other business matters to ensure our audience stays updated with the latest information. We conduct detailed research and fact-check all information before publishing any content to ensure credibility.
Competitive Strengths
Domain-Specific Management Team: Retains a core promoter group possessing deep historical execution experience across private cold-chain networks and specialised domestic corporate logistics fields.
Institutional Asset Expansion Strategy: Uses targeted corporate investments to secure dedicated medical field equipment, diagnostic machinery and real-time transit tracking applications to maintain sample integrity.
Dominant Domestic Network Hubs: Combines multi-city operating terminals across primary urban medical markets including Delhi, Mumbai, Pune and Chennai to handle quick-turnaround diagnostic volumes.
Integrated Medical Logistics Platform: Offers a specialized end-to-end framework combining temperature-regulated sample transportation, residential medical collection and direct hospital staffing options under a single corporate umbrella.
Download regulatory filings
IPO Lot Size
| Investors | No.of lots | Shares Offered | Max Bid Amount |
|---|---|---|---|
| Individual investors (Retail) (Min) | 2 | 1200 | 226800 |
| Individual investors (Retail) (Max) | 2 | 1200 | 226800 |
| S-HNI (Min) | 3 | 1800 | 340200 |
| S-HNI (Max) | 8 | 4800 | 907200 |
| B-HNI (Min) | 9 | 5400 | 1020600 |